Pediatric Cardiology

, Volume 32, Issue 5, pp 659–666 | Cite as

Cellular and RAS Changes in the Hearts of Young Obese Rats

  • Kee Soo Ha
  • Kee Hwan Yoo
  • Hyung Eun Yim
  • Gi Young Jang
  • In Sun Bae
  • Young Sook Hong
  • Joo Won Lee
Original Article


Obesity during childhood increases the risk of cardiac disease, hypertension, and other complications in adulthood. We investigated the cellular and renin-angiotensin system changes of the heart in obese young rats. We used Sprague–Dawley rats and early obesity was induced by overfeeding through adjusting the number of male pups per dam during the first 28 days of life. The body weight, heart weight, blood pressure, serum glucose, and blood pressure were assessed and we performed echocardiography, proliferating cell nuclear antigen (PCNA); assessment, apoptosis and Masson’s trichrome staining, and Western blotting and the results were compared between the normal litter (NL, control) and the small litter (SL, obesity). There were no differences in blood pressure and serum glucose, but the body weight increased 61.2% and the interventricular septal thickness in diastole on the echocardiography was increased in the SL. There was hyperplasia of the PCNA cells and apoptotic cells without cellular hypertrophy or change of the amount of collagen in the SL. On Western blotting, rennin, and angiotensin II type 2 receptor (AT2R) were increased without a change of angiotensin II type 1 receptor (AT1R) in the SL. Early obesity caused echocardiographically detected septal hypertrophy and an increase of cellular turnover. Renin and AT2R were upregulated without a change of AT1R and the increase of AT2R was regarded as a cardioprotective effect against the pathologic conditions caused by the early obesity.


Apoptosis PCNA Hypertrophy Obesity Renin angiotensin system 



This work was supported by the Korea Research Foundation (K. H. Yoo) funded by the Korean Government (grant No. KRF-2008-313-E00308).


  1. 1.
    Baker JL, Olsen LW, Sørensen TI (2007) Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329–2337PubMedCrossRefGoogle Scholar
  2. 2.
    Cayli S, Ustünel I, Celik-Ozenci C, Korgun ET, Demir R (2002) Distribution patterns of PCNA and ANP in perinatal stages of the developing rat heart. Acta Histochem 104:271–277PubMedCrossRefGoogle Scholar
  3. 3.
    Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH (2002) Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 52:325–332PubMedGoogle Scholar
  4. 4.
    D’Amore A, Black MJ, Thomas WG (2005) The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46:1347–1354PubMedCrossRefGoogle Scholar
  5. 5.
    de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology XXIII: the angiotensin II receptors. Pharmacol Rev 52:415–472PubMedGoogle Scholar
  6. 6.
    Dietz WH (1994) Critical periods in childhood for the development of obesity. Am J Clin Nutr 59:955–959PubMedGoogle Scholar
  7. 7.
    Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE (1991) Expression of AT2 receptors in the developing rat fetus. J Clin Invest 88:921–933PubMedCrossRefGoogle Scholar
  8. 8.
    Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T (1993) Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268:24543–24546PubMedGoogle Scholar
  9. 9.
    Kang NS, Yim HE, Bae IS, Choi JH, Choi BM, Yoo KH, Hong YS, Lee JW, Kim SK (2003) ACE inhibition modulates transforming growth factor-beta receptors in the young rat. Pediatr Nephrol 18:865–871PubMedCrossRefGoogle Scholar
  10. 10.
    Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang SS (1994) Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 267:844–852Google Scholar
  11. 11.
    Marino TA, Cao W, Lee J, Courtney R (1996) Localization of proliferating cell nuclear antigen in the developing and mature rat heart cell. Anat Rec 245:677–684PubMedCrossRefGoogle Scholar
  12. 12.
    Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H (1998) Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 101:527–535PubMedCrossRefGoogle Scholar
  13. 13.
    Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182–1191PubMedGoogle Scholar
  14. 14.
    Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663–10667PubMedCrossRefGoogle Scholar
  15. 15.
    Narula J, Kharbanda S, Khaw BA (1997) Apoptosis and the heart. Chest 112:1358–1362PubMedCrossRefGoogle Scholar
  16. 16.
    Samyn ME, Petershack JA, Bedell KA, Mathews MS, Segar JL (1998) Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep. Pediatr Res 44:323–329PubMedCrossRefGoogle Scholar
  17. 17.
    Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, Strom BL (2005) Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 111:1897–1903PubMedCrossRefGoogle Scholar
  18. 18.
    van Kesteren CA, van Heugten HA, Lamers JM, Saxena PR, Schalekamp MA, Danser AH (1997) Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 29:2147–2157PubMedCrossRefGoogle Scholar
  19. 19.
    Virdis A, Ghiadoni L, Masi S, Versari D, Daghini E, Giannarelli C, Salvetti A, Taddei S (2009) Obesity in the childhood: a link to adult hypertension. Curr Pharm 15:1063–1071CrossRefGoogle Scholar
  20. 20.
    Weber MA (1999) Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension. Am J Hypertens 12:189–194CrossRefGoogle Scholar
  21. 21.
    White M (1999) Cardioprotective effect of angiotensin II receptor antagonists. Can J Cardiol 15:10–14Google Scholar
  22. 22.
    Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J, Hirohashi K (2005) Left ventricular hypertrophy and angiotensin II receptor blocking agents. Curr Med Chem Cardiovasc Hematol Agents 3:61–67PubMedCrossRefGoogle Scholar
  23. 23.
    Yoo KH, Wolstenholme JT, Chevalier RL (1997) Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr Res 42:588–592PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Kee Soo Ha
    • 1
  • Kee Hwan Yoo
    • 1
  • Hyung Eun Yim
    • 1
  • Gi Young Jang
    • 1
  • In Sun Bae
    • 1
  • Young Sook Hong
    • 1
  • Joo Won Lee
    • 1
    • 2
  1. 1.Department of Pediatrics, College of MedicineKorea UniversitySeoulSouth Korea
  2. 2.Department of Pediatrics, Guro HospitalKorea University Medical CenterSeoulSouth Korea

Personalised recommendations